Back

Residual stroke risk of anticoagulated patients with atrial fibrillation: PREFER in AF European registry.

28 August 2017 (14:00 - 18:00)
Organised by:
Congress Presentation Part of: Poster session 5 - Registries and cost of treatment Atrial fibrillation (AF) ESC Premium Access ESC Congress 2017

About the speaker

Photo
Doctor Miklos Rohla

Bern University Hospital, Inselspital, Bern (Switzerland)

11 More presentations in this session

Presentation thumbnail
Mr P. Cozzolino (Monza, IT)
Abstract Slides
Presentation thumbnail
Miss M. Lee (Tainan, TW)
Abstract
Presentation thumbnail
Associate Professor M. Proietti (Milan, IT)
Abstract Slides
Presentation thumbnail
Doctor W. Berger (Nieuwegein, NL)
Abstract
Presentation thumbnail
Doctor K. Szummer (Stockholm, SE)
Abstract Slides

Access the full session

Session thumbnail
Poster session 5 - Registries and cost of treatment

The Event

Event poster

ESC Congress 2017

28 August 2017 14:00 CET
You may be interested in
thumbnail
Congress Presentation
Incidence and risk factors for residual adverse events despite anticoagulation in atrial fibrillation: results from phase II/III of the GLORIA-AF registry
27 August 2022
thumbnail
Webinar
Balancing stroke and bleeding risks in patients with AF and concomitant coronary artery disease, malignancy, chronic kidney disease, or frailty
10 November 2025
thumbnail
Congress Presentation
Adherence and treatment satisfaction among atrial fibrillation patients treated with VKAs versus NOACs: real-world data from a single-center cohort
12 April 2026
thumbnail
Congress Presentation
A new clinical decision support tool based on personalized evidence-based medicine improves outcomes of anticoagulation therapy in patients with atrial fibrillation: an analysis from the AF Registry
29 June 2021

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources